• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSB2200070 斯鲁利单抗注射液 Serplulimab Injection Biological Products(1) Supplementary Application 2022-09-07 Shanghai Henlius Biotech Co Ltd view
CXSB2400040 斯鲁利单抗注射液 Serplulimab Injection Biological Products Supplementary Application 2024-04-26 Shanghai Henlius Biopharmaceutical Co Ltd;Shanghai Henlius Biotech Co Ltd view
CXSL2101124 斯鲁利单抗注射液 Serplulimab Injection Biological Products(1) New Drug Application 2021-06-17 Shanghai Henlius Biotech Co Ltd view
CXSL2101343 斯鲁利单抗注射液 Serplulimab Injection Biological Products(1) New Drug Application 2021-09-26 Shanghai Henlius Biotech Co Ltd view
CXSL2200040 斯鲁利单抗注射液 Serplulimab Injection Biological Products(1) New Drug Application 2022-01-24 Shanghai Henlius Biotech Co Ltd view
CXSL2200078 斯鲁利单抗注射液 Serplulimab Injection Biological Products(1) New Drug Application 2022-02-11 Shanghai Henlius Biotech Co Ltd view
CXSL2200105 斯鲁利单抗注射液 Serplulimab Injection Biological Products(1) New Drug Application 2022-02-25 Shanghai Henlius Biotech Co Ltd view
CXSL2200385 斯鲁利单抗注射液 Serplulimab Injection Biological Products(1) New Drug Application 2022-08-22 Shanghai Henlius Biotech Co Ltd view
CXSS2101000 斯鲁利单抗注射液 Serplulimab Injection Biological Products(1) New Drug Application 2021-04-23 Shanghai Henlius Biopharmaceutical Co Ltd view
CXSS2101030 斯鲁利单抗注射液 Serplulimab Injection Biological Products(1) New Drug Application 2021-09-16 Shanghai Henlius Biopharmaceutical Co Ltd view
CXSS2200037 斯鲁利单抗注射液 Serplulimab Injection Biological Products(2.2) New Drug Application 2022-04-11 Shanghai Henlius Biopharmaceutical Co Ltd view
CXSS2200076 斯鲁利单抗注射液 Serplulimab Injection Biological Products(2.2) New Drug Application 2022-08-26 Shanghai Henlius Biopharmaceutical Co Ltd view
CXSS2300094 斯鲁利单抗注射液 Serplulimab Injection Biological Products(2.2) New Drug Application 2023-12-12 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2200260 斯鲁利单抗注射液 Serplulimab Injection Biological Products Supplementary Application 2022-11-18 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2300059 斯鲁利单抗注射液 Serplulimab Injection Biological Products Supplementary Application 2023-03-10 Shanghai Henlius Biologics Co Ltd;Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2300114 斯鲁利单抗注射液 Serplulimab Injection Biological Products Supplementary Application 2023-06-13 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2300232 斯鲁利单抗注射液 Serplulimab Injection Biological Products Supplementary Application 2023-12-12 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2400115 斯鲁利单抗注射液 Serplulimab Injection Biological Products Supplementary Application 2024-05-15 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2400291 斯鲁利单抗注射液 Serplulimab Injection Biological Products Supplementary Application 2024-11-08 Shanghai Henlius Biopharmaceutical Co Ltd view
CYSB2500093 斯鲁利单抗注射液 Serplulimab Injection Biological Products Supplementary Application 2025-04-28 Shanghai Henlius Biopharmaceutical Co Ltd view